Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2007-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1158/1535-7163.MCT-06-0727PMID 17513602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance

  2006cited by this paper
• Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

  2006cited by this paper
• E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.

  2006cited by this paper
• Discovery and evaluation of dual CDK1 and CDK2 inhibitors.

  2006cited by this paper
• Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment

  2006cited by this paper
• Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells

  2006cited by this paper
• Cyclin-dependent kinase pathways as targets for cancer treatment.

  2006cited by this paper
• Mitosis: a matter of getting rid of the right protein at the right time.

  2006cited by this paper
• 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells.

  2006cited by this paper
• Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

  2006cited by this paper
• Prostate epithelial stem cells

  2005cited by this paper
• p53 Activation by small molecules: application in oncology.

  2005cited by this paper
• Krüppel‐like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras‐mediated transformation

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• Loss of Cyclin B1 followed by downregulation of Cyclin A/Cdk2, apoptosis and antiproliferation in Hela cell line

  2005cited by this paper
• A tumour stem cell hypothesis for the origins of prostate cancer

  2005cited by this paper
• Phosphorylation of BAD at Ser‐128 during mitosis and paclitaxel‐induced apoptosis

  2005cited by this paper
• Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor‐associated antigens

  2005cited by this paper
• Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A Review

  2005cited by this paper
• Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities.

  2005influential reference
• Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function.

  2005cited by this paper
• Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

  2004cited by this paper
• Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

  2004cited by this paper
• 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate

  2004cited by this paper
• Living with or without cyclins and cyclin-dependent kinases.

  2004cited by this paper
• with follicular lymphoma High expression of cyclin B 1 predicts a favorable outcome in patients

  2004cited by this paper
• Prognostic value of cyclin B1 protein expression in colorectal cancer.

  2004cited by this paper
• Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells

  2004cited by this paper
• New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent

  2003cited by this paper
• The Bcl-2 family: roles in cell survival and oncogenesis

  2003cited by this paper
• Proliferation of cancer cells despite CDK2 inhibition.

  2003cited by this paper
• Molecular characterization of human prostate carcinoma cell lines

  2003influential reference
• Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma

  2002cited by this paper
• Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

  2002cited by this paper
• Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery.

  2002cited by this paper
• Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.

  2002cited by this paper
• Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

  2001cited by this paper
• Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells

  2001cited by this paper
• Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.

  2001cited by this paper
• 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.

  2001cited by this paper
• Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.

  2000cited by this paper
• Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

  2000cited by this paper
• Abundance of cyclin B1 regulates γ-radiation–induced apoptosis

  2000cited by this paper
• The tumour suppressor protein p53 can repress transcription of cyclin B.

  2000cited by this paper
• Abundance of cyclin B1 regulates gamma-radiation-induced apoptosis.

  2000cited by this paper
• Age‐Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow

  1999cited by this paper
• The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma

  1999cited by this paper
• p53 regulates a G2 checkpoint through cyclin B1.

  1999cited by this paper
• Delayed early embryonic lethality following disruption of the murine cyclin A2 gene

  1999cited by this paper
• Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero.

  1998cited by this paper
• Prognostic factors in gastric cancer.

  1998cited by this paper
• Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.

  1997cited by this paper
• Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration

  1996cited by this paper
• SV40 T antigen increases the expression and activities of p34cdc2, cyclin A, and cyclin B prior to immortalization of human diploid fibroblasts

  1996cited by this paper
• Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.

  1996cited by this paper
• Expression of cell cycle-regulated proteins in prostate cancer.

  1996cited by this paper
• The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B.

  1994cited by this paper
• Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.

  1994cited by this paper
• Distinct roles for cyclin-dependent kinases in cell cycle control.

  1993cited by this paper
• Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

  1992influential reference
• [Prognostic factors in gastric cancer].

  1988cited by this paper

• Co-formulation of folate supplement leucovorin calcium in glucocorticoid receptor-targeted liposomal formulation inducing efficient colorectal tumor regression

  2026cites this paper
• Naphthalimide derivative attenuates tumor growth of wild-type p53-expressing U87 glioma cells in vitro and in vivo through a biphasic dose-dependent mechanism: A switch from cell cycle to apoptosis.

  2025cites this paper
• Multi-omics insights into the roles of CCNB1, PLK1, and HPSE in breast cancer progression: implications for prognosis and immunotherapy

  2025cites this paper
• NL13, a novel curcumin analogue and polo like kinase 4 inhibitor, induces cell cycle arrest and apoptosis in prostate cancer models

  2024cites this paper
• Anticancer Effect by Combined Treatment of Artemisia annua L. Polyphenols and Docetaxel in DU145 Prostate Cancer Cells and HCT116 Colorectal Cancer Cells

  2024cites this paper
• Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents

  2024cites this paper
• Forced Vasohibin‐1 Expression Increases Paclitaxel Sensitivity of Ovarian Cancer by Inhibiting Microtubule Activity

  2024cites this paper
• Bioinformatics-based screening of hub genes for prostate cancer bone metastasis and analysis of immune infiltration

  2024cites this paper
• Cockayne syndrome group A protein localizes at centrosomes during mitosis and regulates Cyclin B1 ubiquitination.

  2023cites this paper
• New Propargyloxy Derivatives of Galangin, Kaempferol and Fisetin—Synthesis, Spectroscopic Analysis and In Vitro Anticancer Activity on Head and Neck Cancer Cells

  2023cites this paper
• Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer

  2023cites this paper
• The role of cyclins in the development and progression of prostate cancer.

  2022cites this paper
• Identification of Critical Molecular Factors and Side Effects Underlying the Response to Thalicthuberine in Prostate Cancer: A Systems Biology Approach

  2022cites this paper
• CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine

  2022cites this paper
• The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development

  2022cites this paper
• DMA, a Small Molecule, Increases Median Survival and Reduces Radiation-Induced Xerostomia via the Activation of the ERK1/2 Pathway in Oral Squamous Cell Carcinoma

  2022cites this paper
• Identification of novel biomarkers in prostate cancer diagnosis and prognosis

  2022cites this paper
• Identification of potential core genes in esophageal carcinoma using bioinformatics analysis

  2021cites this paper
• Association of chromosome 6 open reading frame 106 in different cancers.

  2021cites this paper
• Diarylpentanoid (1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one) (MS13) Exhibits Anti-proliferative, Apoptosis Induction and Anti-migration Properties on Androgen-independent Human Prostate Cancer by Targeting Cell Cycle–Apoptosis and PI3K Signalling Pathways

  2021cites this paper
• Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

  2021cites this paper
• Identification of core genes associated with prostate cancer progression and outcome via bioinformatics analysis in multiple databases

  2020cites this paper
• Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.

  2020cites this paper
• Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer

  2020cites this paper
• Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis

  2020cites this paper
• Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model

  2019cites this paper
• Regulation of p21 expression for anti-apoptotic activity of DDX3 against sanguinarine-induced cell death on intrinsic pathway.

  2019cites this paper
• Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis

  2018cites this paper
• Prognostic role of cyclin B1 in solid tumors: a meta-analysis

  2016cites this paper
• Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells

  2016cites this paper
• 14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression

  2016cites this paper
• Cyclin B in Oral Squamous Cell Carcinoma –Mini Review

  2015cites this paper
• Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells.

  2014cites this paper
• Evaluation of Schistosome Promoter Expression for Transgenesis and Genetic Analysis

  2014cites this paper
• The prognostic value of Cyclin B1 in pancreatic cancer

  2014cites this paper
• BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents.

  2013cites this paper
• Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells

  2013cites this paper
• 12-Deoxyphorbol 13-palmitate mediated cell growth inhibition, G2-M cell cycle arrest and apoptosis in BGC823 cells.

  2013cites this paper
• Prognostic Value of Discs Large Homolog 7 Transcript Levels in Prostate Cancer

  2013cites this paper
• Cykliny jako markery chorób nowotworowych

  2012cites this paper
• Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases

  2012cites this paper
• The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis

  2012cites this paper
• Effects of 2‐methoxyestradiol on proliferation, apoptosis and gene expression of cyclin B1 and c‐Myc in esophageal carcinoma EC9706 cells

  2012cites this paper
• Inhibition of Progression of Androgen-Dependent Prostate LNCaP Tumors to Androgen Independence in SCID Mice by Oral Caffeine and Voluntary Exercise

  2012cites this paper
• Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.

  2012cites this paper
• Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel

  2012cites this paper
• The Bacterial Protein Azurin Enhances Sensitivity of Oral Squamous Carcinoma Cells to Anticancer Drugs

  2011cites this paper
• Silencing of Her2, CCNB1 and PKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division

  2011cites this paper
• Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells.

  2010cites this paper
• Silencing of the CCNB1, Her2, and PKC genes by small interfering RNA differently retards the division of different human cancer cell lines

  2010cites this paper
• Tissue inhibitor of metalloproteinase‐1 protects MCF‐7 breast cancer cells from paclitaxel‐induced apoptosis by decreasing the stability of cyclin B1

  2010cites this paper
• NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells

  2010cites this paper
• HIV‐1 Tat regulates cyclin B1 by promoting both expression and degradation

  2010cites this paper
• Hip2 interacts with cyclin B1 and promotes its degradation through the ubiquitin proteasome pathway

  2010cites this paper
• Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis.

  2009cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2009cites this paper
• A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.

  2009cites this paper
• Effects of Nickel on Cyclin Expression, Cell Cycle Progression and Cell Proliferation in Human Pulmonary Cells

  2009cites this paper
• Pretreatment of docetaxel enhances TRAIL‐mediated apoptosis in prostate cancer cells

  2008influential citation
• Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells

  2008cites this paper
• Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.

  2008cites this paper
• Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells

  year unknowncites this paper